DEA Ends Its Monopoly On Marijuana Growing For Medical Research

Other potential growers might include big agricultural and pharmaceutical companies that have been pondering entering the pot market but have sat on the sidelines, waiting for the DEA to loosen its rules. The DEA says the new policy is designed to enable companies seeking to market particular strains of marijuana as prescription drugs to start developing products.

WASHINGTON — The federal government is ending its decades-old monopoly on marijuana production for medical research as the Drug Enforcement Agency announced Thursday it was bowing to changing times. The agency said it would begin allowing researchers and drug companies to use pot grown in places other than its well-secured facility at the University of Mississippi.…

Recommended posts powered by Google